nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Respiratory tract congestion—Varenicline—nicotine dependence	0.045	0.0532	CcSEcCtD
Trospium—Coronary artery disease—Varenicline—nicotine dependence	0.0415	0.0491	CcSEcCtD
Trospium—Hoarseness—Varenicline—nicotine dependence	0.0373	0.0441	CcSEcCtD
Trospium—Urine abnormality—Varenicline—nicotine dependence	0.0296	0.0351	CcSEcCtD
Trospium—Urine analysis abnormal—Varenicline—nicotine dependence	0.0279	0.033	CcSEcCtD
Trospium—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0251	0.0296	CcSEcCtD
Trospium—Dysphonia—Varenicline—nicotine dependence	0.02	0.0236	CcSEcCtD
Trospium—Endocrine disorder—Varenicline—nicotine dependence	0.0198	0.0234	CcSEcCtD
Trospium—Methadone—CHRNA10—nicotine dependence	0.0194	0.779	CrCbGaD
Trospium—Influenza like illness—Varenicline—nicotine dependence	0.0159	0.0188	CcSEcCtD
Trospium—Dry eye—Varenicline—nicotine dependence	0.0152	0.0179	CcSEcCtD
Trospium—Mouth ulceration—Varenicline—nicotine dependence	0.0148	0.0175	CcSEcCtD
Trospium—Lymphadenopathy—Varenicline—nicotine dependence	0.014	0.0165	CcSEcCtD
Trospium—Eczema—Varenicline—nicotine dependence	0.0133	0.0157	CcSEcCtD
Trospium—Eye pain—Varenicline—nicotine dependence	0.0132	0.0156	CcSEcCtD
Trospium—Hot flush—Varenicline—nicotine dependence	0.0127	0.0151	CcSEcCtD
Trospium—Menopausal symptoms—Varenicline—nicotine dependence	0.0126	0.0149	CcSEcCtD
Trospium—Thirst—Varenicline—nicotine dependence	0.0125	0.0148	CcSEcCtD
Trospium—Migraine—Varenicline—nicotine dependence	0.0117	0.0139	CcSEcCtD
Trospium—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0116	0.0897	CbGpPWpGaD
Trospium—Urinary retention—Varenicline—nicotine dependence	0.0113	0.0134	CcSEcCtD
Trospium—Dry skin—Varenicline—nicotine dependence	0.0109	0.0129	CcSEcCtD
Trospium—Abdominal pain upper—Varenicline—nicotine dependence	0.0109	0.0129	CcSEcCtD
Trospium—Breast disorder—Varenicline—nicotine dependence	0.0108	0.0127	CcSEcCtD
Trospium—Cramp muscle—Varenicline—nicotine dependence	0.0107	0.0127	CcSEcCtD
Trospium—Nasopharyngitis—Varenicline—nicotine dependence	0.0107	0.0126	CcSEcCtD
Trospium—Gastritis—Varenicline—nicotine dependence	0.0105	0.0125	CcSEcCtD
Trospium—Abdominal distension—Varenicline—nicotine dependence	0.0104	0.0123	CcSEcCtD
Trospium—Angina pectoris—Varenicline—nicotine dependence	0.01	0.0119	CcSEcCtD
Trospium—Abdominal discomfort—Varenicline—nicotine dependence	0.00987	0.0117	CcSEcCtD
Trospium—Pollakiuria—Varenicline—nicotine dependence	0.00951	0.0112	CcSEcCtD
Trospium—Photosensitivity reaction—Varenicline—nicotine dependence	0.0094	0.0111	CcSEcCtD
Trospium—Weight increased—Varenicline—nicotine dependence	0.00937	0.0111	CcSEcCtD
Trospium—Infestation NOS—Varenicline—nicotine dependence	0.00918	0.0109	CcSEcCtD
Trospium—Infestation—Varenicline—nicotine dependence	0.00918	0.0109	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0091	0.0108	CcSEcCtD
Trospium—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00905	0.07	CbGpPWpGaD
Trospium—Stomatitis—Varenicline—nicotine dependence	0.00895	0.0106	CcSEcCtD
Trospium—Hallucination—Varenicline—nicotine dependence	0.0082	0.0097	CcSEcCtD
Trospium—Urinary tract disorder—Varenicline—nicotine dependence	0.00814	0.00963	CcSEcCtD
Trospium—Oedema peripheral—Varenicline—nicotine dependence	0.00812	0.0096	CcSEcCtD
Trospium—Connective tissue disorder—Varenicline—nicotine dependence	0.0081	0.00958	CcSEcCtD
Trospium—Urethral disorder—Varenicline—nicotine dependence	0.00808	0.00955	CcSEcCtD
Trospium—Visual impairment—Varenicline—nicotine dependence	0.00794	0.00939	CcSEcCtD
Trospium—Erythema multiforme—Varenicline—nicotine dependence	0.00779	0.00922	CcSEcCtD
Trospium—Eye disorder—Varenicline—nicotine dependence	0.0077	0.00911	CcSEcCtD
Trospium—Cardiac disorder—Varenicline—nicotine dependence	0.00765	0.00905	CcSEcCtD
Trospium—Angiopathy—Varenicline—nicotine dependence	0.00748	0.00884	CcSEcCtD
Trospium—Mediastinal disorder—Varenicline—nicotine dependence	0.00743	0.00878	CcSEcCtD
Trospium—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00719	0.0556	CbGpPWpGaD
Trospium—Malnutrition—Varenicline—nicotine dependence	0.00718	0.00848	CcSEcCtD
Trospium—Flatulence—Varenicline—nicotine dependence	0.00707	0.00836	CcSEcCtD
Trospium—Dysgeusia—Varenicline—nicotine dependence	0.00703	0.00831	CcSEcCtD
Trospium—Back pain—Varenicline—nicotine dependence	0.00694	0.00821	CcSEcCtD
Trospium—Muscle spasms—Varenicline—nicotine dependence	0.0069	0.00816	CcSEcCtD
Trospium—Vision blurred—Varenicline—nicotine dependence	0.00676	0.008	CcSEcCtD
Trospium—Angioedema—Varenicline—nicotine dependence	0.00656	0.00775	CcSEcCtD
Trospium—Syncope—Varenicline—nicotine dependence	0.00644	0.00761	CcSEcCtD
Trospium—Palpitations—Varenicline—nicotine dependence	0.00634	0.0075	CcSEcCtD
Trospium—Loss of consciousness—Varenicline—nicotine dependence	0.00631	0.00746	CcSEcCtD
Trospium—Chest pain—Varenicline—nicotine dependence	0.00611	0.00722	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00607	0.00717	CcSEcCtD
Trospium—Dry mouth—Varenicline—nicotine dependence	0.00597	0.00706	CcSEcCtD
Trospium—Oedema—Varenicline—nicotine dependence	0.00586	0.00692	CcSEcCtD
Trospium—Infection—Varenicline—nicotine dependence	0.00582	0.00688	CcSEcCtD
Trospium—Shock—Varenicline—nicotine dependence	0.00576	0.00681	CcSEcCtD
Trospium—Nervous system disorder—Varenicline—nicotine dependence	0.00574	0.00679	CcSEcCtD
Trospium—Tachycardia—Varenicline—nicotine dependence	0.00572	0.00676	CcSEcCtD
Trospium—Skin disorder—Varenicline—nicotine dependence	0.00569	0.00673	CcSEcCtD
Trospium—Hyperhidrosis—Varenicline—nicotine dependence	0.00566	0.00669	CcSEcCtD
Trospium—Methadone—OPRM1—nicotine dependence	0.0055	0.221	CrCbGaD
Trospium—Somnolence—Varenicline—nicotine dependence	0.00521	0.00616	CcSEcCtD
Trospium—Dyspepsia—Varenicline—nicotine dependence	0.00516	0.0061	CcSEcCtD
Trospium—Decreased appetite—Varenicline—nicotine dependence	0.00509	0.00602	CcSEcCtD
Trospium—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00506	0.00598	CcSEcCtD
Trospium—Fatigue—Varenicline—nicotine dependence	0.00505	0.00597	CcSEcCtD
Trospium—Constipation—Varenicline—nicotine dependence	0.00501	0.00592	CcSEcCtD
Trospium—Feeling abnormal—Varenicline—nicotine dependence	0.00483	0.00571	CcSEcCtD
Trospium—Gastrointestinal pain—Varenicline—nicotine dependence	0.00479	0.00566	CcSEcCtD
Trospium—Urticaria—Varenicline—nicotine dependence	0.00465	0.0055	CcSEcCtD
Trospium—Abdominal pain—Varenicline—nicotine dependence	0.00463	0.00547	CcSEcCtD
Trospium—Asthenia—Varenicline—nicotine dependence	0.0042	0.00497	CcSEcCtD
Trospium—Pruritus—Varenicline—nicotine dependence	0.00414	0.0049	CcSEcCtD
Trospium—Dizziness—Varenicline—nicotine dependence	0.00387	0.00458	CcSEcCtD
Trospium—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00382	0.0296	CbGpPWpGaD
Trospium—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00381	0.0295	CbGpPWpGaD
Trospium—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00377	0.0292	CbGpPWpGaD
Trospium—Vomiting—Varenicline—nicotine dependence	0.00372	0.0044	CcSEcCtD
Trospium—Rash—Varenicline—nicotine dependence	0.00369	0.00437	CcSEcCtD
Trospium—Dermatitis—Varenicline—nicotine dependence	0.00369	0.00436	CcSEcCtD
Trospium—Headache—Varenicline—nicotine dependence	0.00367	0.00434	CcSEcCtD
Trospium—Nausea—Varenicline—nicotine dependence	0.00348	0.00411	CcSEcCtD
Trospium—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00321	0.0248	CbGpPWpGaD
Trospium—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0032	0.0248	CbGpPWpGaD
Trospium—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00317	0.0245	CbGpPWpGaD
Trospium—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00299	0.0231	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00295	0.0228	CbGpPWpGaD
Trospium—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00295	0.0228	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00294	0.0227	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00291	0.0225	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00257	0.0199	CbGpPWpGaD
Trospium—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00242	0.0187	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00221	0.0171	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00183	0.0142	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00183	0.0141	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00181	0.014	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00176	0.0136	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00175	0.0135	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00174	0.0134	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00158	0.0122	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00157	0.0122	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00156	0.0121	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00147	0.0114	CbGpPWpGaD
Trospium—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00136	0.0105	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00134	0.0103	CbGpPWpGaD
Trospium—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00129	0.00994	CbGpPWpGaD
Trospium—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00127	0.0098	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00122	0.00942	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00109	0.00839	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00102	0.00789	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00102	0.00786	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00101	0.00779	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000901	0.00696	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000892	0.0069	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00089	0.00688	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000881	0.00681	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000874	0.00676	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000871	0.00674	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000863	0.00667	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00081	0.00626	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000808	0.00625	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.0008	0.00618	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000785	0.00607	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000738	0.0057	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000735	0.00568	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000728	0.00563	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.0007	0.00541	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000698	0.0054	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000691	0.00534	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000666	0.00515	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000664	0.00513	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000657	0.00508	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000636	0.00492	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000634	0.0049	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000632	0.00489	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00063	0.00487	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000628	0.00485	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000624	0.00482	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000481	0.00372	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.00048	0.00371	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000479	0.0037	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000477	0.00369	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000475	0.00367	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000473	0.00365	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000376	0.00291	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000376	0.0029	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000375	0.0029	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000374	0.00289	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000371	0.00287	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000371	0.00287	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000368	0.00284	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000342	0.00264	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000341	0.00263	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000337	0.00261	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000332	0.00257	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000331	0.00256	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000328	0.00253	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000272	0.0021	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000271	0.0021	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000268	0.00208	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000247	0.00191	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000246	0.0019	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000244	0.00188	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000234	0.00181	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000233	0.0018	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000231	0.00178	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000224	0.00173	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000223	0.00173	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000221	0.00171	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.00022	0.0017	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000202	0.00156	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000201	0.00156	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000199	0.00154	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000146	0.00113	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000145	0.00112	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000144	0.00111	CbGpPWpGaD
